Epigenetic silencing of MAFG is a potential prognosis biomarker in lung adenocarcinomas
Álvaro García-Guede, Carlos Rodríguez‐Antolín, Ana Arauzo-Cabrera…·Olga Vera
The paper investigates MAFG's role in DNA methylation remodeling in NSCLC, finding that MAFG methylation and protein levels are prognostic biomarkers, especially in lung adenocarcinomas.